Docoh
Loading...

54 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PCSA Processa Pharmaceuticals Inc
22 Apr 21
Definitive proxy
2:00pm
on capital; return on assets; operating working capital; average accounts receivable; economic value added; total stockholder return; customer satisfaction … ; operating margin; profit margin; sales performance; sales quota attainment; new sales; cross/integrated sales; customer engagement; internal revenue
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
products, as well as the marketing and customer acceptance of such products; unexpected issues with the FDA, other federal or state regulatory … of sensitive information. In the course of doing business, we collect employee, customer and other third-party data, including personally identifiable
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am
information, including but not limited to manufacturing techniques, processes, formulas, customer lists, inventions, experimental developments, research
424B4
PCSA Processa Pharmaceuticals Inc
5 Oct 20
Prospectus supplement with pricing info
4:16pm
and development efforts resulting in successful commercial products, as well as the marketing and customer acceptance of such products; unexpected … with the collection, handling, storage and transmission of sensitive information. In the course of doing business, we collect employee, customer
S-1/A
PCSA Processa Pharmaceuticals Inc
30 Sep 20
IPO registration (amended)
4:06pm
in successful commercial products, as well as the marketing and customer acceptance of such products; unexpected issues with the FDA, other federal … and transmission of sensitive information. In the course of doing business, we collect employee, customer and other third-party data, including
S-1/A
5l4cx24t
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.4
a2r7 2zmskihdlol2sr8
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.5
2eibngep
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
za1rdtp3g0yroyw
17 Jul 20
IPO registration (amended)
5:25pm
10-K
u0va topjyv
5 Mar 20
Annual report
7:00pm
S-1
xahuafzsdo55d
13 Dec 19
IPO registration
5:32pm
DEF 14A
5tl5jhn
26 Apr 19
Definitive proxy
5:02pm
10-K/A
u1oa9
5 Apr 19
Annual report (amended)
9:40pm
10-K
u6q1g 8tn
28 Mar 19
Annual report
5:25pm
424B3
g2np ndop
9 Nov 18
Prospectus supplement
5:04pm
S-1/A
ccsgjzzewstoytu
30 Oct 18
IPO registration (amended)
4:19pm
S-1/A
z984 k1s2z
9 Oct 18
IPO registration (amended)
5:32pm
S-1/A
uj9eifqg4yju
13 Sep 18
IPO registration (amended)
8:00pm
8-K
EX-10.1
6402 ilzbhltg
9 Sep 18
Departure of Directors or Certain Officers
8:00pm
S-1
fpaytb
29 Jul 18
IPO registration
8:00pm